(19)
(11) EP 2 618 825 A1

(12)

(43) Date of publication:
31.07.2013 Bulletin 2013/31

(21) Application number: 11827867.0

(22) Date of filing: 16.09.2011
(51) International Patent Classification (IPC): 
A61K 31/35(2006.01)
A61P 31/20(2006.01)
(86) International application number:
PCT/CA2011/050567
(87) International publication number:
WO 2012/040841 (05.04.2012 Gazette 2012/14)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

(30) Priority: 21.09.2010 US 384778 P

(71) Applicant: Her Majesty The Queen In Right of Canada as represented by The Minister of Health
Winnipeg, Manitoba R3E 3P6 (CA)

(72) Inventors:
  • MYSKIW, Chad
    Winnipeg, Manitoba R3E 3P6 (CA)
  • CAO, Jingxin
    Winnipeg, Manitoba R3E 3P9 (CA)
  • HE, Runtao
    Winnipeg, Manitoba R3E 3P9 (CA)

(74) Representative: Nederlandsch Octrooibureau 
P.O. Box 29720
2502 LS The Hague
2502 LS The Hague (NL)

   


(54) USE OF NIGERICIN TO TREAT AND PREVENT VACCINIA VIRUS INFECTIONS